STAT3 and head and neck neoplasm: As the first demonstration of UTMC-mediated delivery of STAT3 decoy to cancer cells of human origin, these data set the stage for clinical translation of ultrasound-mediated delivery of STAT3 decoy for the treatment of patients with head and neck tumors.